Records containing: Leukemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-18A Phase 1 Study of Cytokine-induced Memory-like (CIML) NK Cells With Venetoclax as Consolidation Therapy in AML
-
CLINICAL_TRIALS study record update · 2026-03-11A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2026-03-10Clinical Study on the Safety and Efficacy of BiTE-EV Therapy in Relapsed/Refractory Acute B-Cell Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2026-03-09Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2026-03-05Combination of Nivolumab and Ipilimumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-05A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia
-
CLINICAL_TRIALS study record update · 2026-03-04A Single-Arm, Open-Label, Multicenter Phase 2 Study to Evaluate the Efficacy and Safety of BCL2 Inhibitor BGB-11417 in Adult Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
-
CLINICAL_TRIALS study record update · 2026-03-04CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
-
CLINICAL_TRIALS study record update · 2026-03-04Spiritual Care to Optimize Relationships and Experience in Adults With Acute Leukemia (SCORE Trial)
-
CLINICAL_TRIALS study record update · 2026-03-03Safety of Targeting PI3Kgamma Signaling With Azacitidine, Venetoclax and Eganelisib in Acute Myeloid Leukemia: A Phase 1 Study (GAVEL)
-
CLINICAL_TRIALS study record update · 2026-02-27Digital Intervention to Promote Physical Activity and Improve Cardiovascular Health Among Cancer Survivors
-
CLINICAL_TRIALS study record update · 2026-02-25A Pilot Proof-of-Concept Study of Talazoparib-Based Therapy for Cohesin-Mutated AML and MDS With Excess Blasts
-
CLINICAL_TRIALS study record update · 2026-02-24Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)
-
CLINICAL_TRIALS study record update · 2026-02-24Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease
-
CLINICAL_TRIALS study record update · 2026-02-20The Impact of a Non-Profit Cancer Advocacy Organization on Patient Reported Outcomes and Access to Care: A Multisite, Longitudinal Trial
-
CLINICAL_TRIALS study record update · 2026-02-20Expanded Access Protocol Using CD3+/CD19+ Depleted Unrelated Donor or Related Donor Peripheral Stem Cells
-
CLINICAL_TRIALS study record update · 2026-02-19A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
-
CLINICAL_TRIALS study record update · 2026-02-18A Phase I Study of Venetoclax Combined With Vyxeos (CPX-351) for Children, Adolescents and Young Adults With Relapsed or Refractory Acute Leukemia
-
CLINICAL_TRIALS study record update · 2026-02-18Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-07: A Phase 1/2 Study of CD22-Specific CAR T Cells for CD22+ Leukemia or Lymphoma
-
CLINICAL_TRIALS study record update · 2026-02-18A Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution in Children and Young Adults With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2026-02-12National Longitudinal Cohort of Hematological Diseases (NICHE)
-
CLINICAL_TRIALS study record update · 2026-02-12A Family-based Intervention Approach to Address Weight Gain in Pediatric Leukemia Survivors
-
CLINICAL_TRIALS study record update · 2026-02-12A Phase II Study of the BRAF Inhibitor, Vemurafenib, Plus Obinutuzumab in Patients With Previously Untreated Classical Hairy Cell Leukemia
-
CLINICAL_TRIALS study record update · 2026-02-11A Phase 1/2, Open Label, Study of Roginolisib (IOA-244), an Orally Bioavailable, Selective PI3Kδ Inhibitor in Patients With Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) in Combination With Venetoclax and Rituximab
-
CLINICAL_TRIALS study record update · 2026-02-11A Phase 2 Randomized, Multi-center Study of GEO-CMO4S1 (SARS-CoV-2 Vaccine) Versus mRNA SARS-CoV-2 Vaccine in Patients Post Cellular Therapy for Hematological Malignancies